Important findings from an animal study have prompted the exploration of a gene therapy for Duchenne muscular dystrophy in an ongoing human trial.

Important findings from an animal study have prompted the exploration of a gene therapy for Duchenne muscular dystrophy in an ongoing human trial.
In 2019, CRISPR gene-editing therapy was used for the first time to treat sickle cell disease.
Targeted viral-based gene therapies come with their own risks. A new gene delivery system mimics viral therapies to infect cancer cells with vesicular stomatitis virus matrix protein, with a similar transfection efficiency as the virus itself.
Obesity is a growing epidemic around the world.
Researchers from Case Western Reserve University present an efficient non-viral gene delivery system for safe gene therapy to treat genetic eye disorders.
A reducibly-degradable hyperbranched polymer PEI-SS-HP composed of LMW PEI via a disulfide-containing linkage is demonstrated as a promising gene vector.
A specific epigenetic signature in patients who respond to chemotherapy offers potential to improve treatment.
Stimulating neuron growth using a new mRNA therapy, researchers hope to treat chronic pain caused by disease, injury, or chemotherapy.
Ultrasound therapy, which stimulates neural pathways, just became easier to evaluate, opening the door for better clinical data.
Genomic editing tools can reverse disease causing mutations to provide cures — once we can conquer the remaining barriers.